Arthrocare Up 33.8% Since SmarTrend Uptrend Call (ARTC)
Comtex SmarTrend(R) - Mon Dec 22, 5:09PM CST
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 13 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
Arthrocare Has Returned 33.8% Since SmarTrend Recommendation (ARTC)
Comtex SmarTrend(R) - Mon Dec 15, 11:06AM CST
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 13 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
Uptrend Call Working As Arthrocare Stock Rises 33.8% (ARTC)
Comtex SmarTrend(R) - Mon Dec 08, 10:09AM CST
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 13 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
33.8% Return Seen to Date on SmarTrend Arthrocare Call (ARTC)
Comtex SmarTrend(R) - Mon Dec 01, 9:19AM CST
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 12 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
Arthrocare Shares Up 33.8% Since SmarTrend's Buy Recommendation (ARTC)
Comtex SmarTrend(R) - Fri Nov 21, 4:47PM CST
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 12 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
Shares of ARTC Up 33.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 09, 9:52AM CDT
SmarTrend identified an Uptrend for Arthrocare (NASDAQ:ARTC) on November 25th, 2013 at $36.33. In approximately 11 months, Arthrocare has returned 33.77% as of today's recent price of $48.60.
ARTC: 48.60 (+0.04)
Former Arthrocare Executives Sentenced for Orchestrating $750 Million Securities Fraud Scheme
M2 - Mon Sep 01, 6:25AM CDT
The former chief executive officer (CEO) of ArthroCare Corporation was sentenced to serve 20 years in prison, and the former chief financial officer (CFO) was sentenced to serve 10 years in prison today for their leading roles in a $750 million securities fraud scheme. Two other former senior vice presidents of ArthroCare were also sentenced to prison terms for their roles in the scheme.
ARTC: 48.60 (+0.04)